The Global HIV Epidemic: What Will It Take to Get to the Finish Line?

Ingrid T Katz^{1

2

3}, Peter Ehrenkranz⁴, Wafaa El-Sadr^{5

6}

Affiliations

¹ Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Center for Global Health, Massachusetts General Hospital, Boston.
³ Harvard Medical School, Boston, Massachusetts.
⁴ Global Development, Bill & Melinda Gates Foundation, Seattle, Washington.
⁵ ICAP at Columbia University, New York, New York.
⁶ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Editorial

Ingrid T Katz et al. JAMA. 2018.

. 2018 Mar 20;319(11):1094-1095.

doi: 10.1001/jama.2018.2093.

Ingrid T Katz^{1

2

3}, Peter Ehrenkranz⁴, Wafaa El-Sadr^{5

6}

¹ Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Center for Global Health, Massachusetts General Hospital, Boston.
³ Harvard Medical School, Boston, Massachusetts.
⁴ Global Development, Bill & Melinda Gates Foundation, Seattle, Washington.
⁵ ICAP at Columbia University, New York, New York.
⁶ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

No abstract available

Comment on

Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A, Glass TR. Labhardt ND, et al. JAMA. 2018 Mar 20;319(11):1103-1112. doi: 10.1001/jama.2018.1818. JAMA. 2018. PMID: 29509839 Free PMC article. Clinical Trial.